Related references
Note: Only part of the references are listed.Prognostic significance and therapeutic implications of Caveolin-1 in gastrointestinal tract malignancies
Konstantinos Kamposioras et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer
Adam R. Wolfe et al.
CLINICAL CANCER RESEARCH (2021)
New insights in the expression of stromal caveolin 1 in breast cancer spread to axillary lymph nodes
Cristian Scatena et al.
SCIENTIFIC REPORTS (2021)
Caveola-forming proteins and prostate cancer
Zeyad D. Nassar et al.
CANCER AND METASTASIS REVIEWS (2020)
Tumor-stroma biomechanical crosstalk: a perspective on the role of caveolin-1 in tumor progression
Fidel Nicolas Lolo et al.
CANCER AND METASTASIS REVIEWS (2020)
Stromal CAVIN1 Controls Prostate Cancer Microenvironment and Metastasis by Modulating Lipid Distribution and Inflammatory Signaling
Jin-Yih Low et al.
MOLECULAR CANCER RESEARCH (2020)
Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma
Jianxing Yin et al.
EBIOMEDICINE (2019)
Simvastatin delays castration-resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin-1
Yingying Gao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Cavin-1/PTRF mediates insulin-dependent focal adhesion remodeling and ameliorates high-fat diet-induced inflammatory responses in mice
Hong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1
Wenjun Pu et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Rack1 mediates Src binding to drug transporter P-glycoprotein and modulates its activity through regulating Caveolin-1 phosphorylation in breast cancer cells
Yanling Fan et al.
CELL DEATH & DISEASE (2019)
Progression-Related Loss of Stromal Caveolin 1 Levels Mediates Radiation Resistance in Prostate Carcinoma via the Apoptosis Inhibitor TRIAP1
Julia Ketteler et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Proteomic identification of a marker signature for MAPKi resistance in melanoma
Verena Paulitschke et al.
EMBO JOURNAL (2019)
Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients
Qing Guo et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model
Konstantinos Kamposioras et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Caveolin-1 expression as a prognostic marker in triple negative breast cancers of Asian women
Joe Yeong et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)
Matthew Sung et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Caveolin-1, cancer and therapy resistance
Julia Ketteler et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Metformin-induced caveolin-1 expression promotes T-DM1 drug efficacy in breast cancer cells
Yuan-Chiang Chung et al.
SCIENTIFIC REPORTS (2018)
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer
Pinar Kanlikilicer et al.
EBIOMEDICINE (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
PTRF suppresses the progression of colorectal cancers
Fengyun Wang et al.
ONCOTARGET (2017)
Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma
HaiLong Ruan et al.
EXPERIMENTAL CELL RESEARCH (2017)
Anti-neoplastic drugs increase caveolin-1-dependent migration, invasion and metastasis of cancer cells
Natalia I. Diaz-Valdivia et al.
ONCOTARGET (2017)
Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance
Andrej Panic et al.
SCIENTIFIC REPORTS (2017)
Caveolae-Mediated Endocytosis Is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy
Moumita Chatterjee et al.
CANCER RESEARCH (2017)
Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis
Young Seok Lee et al.
TUMOR BIOLOGY (2016)
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer
Mariko Kikuchi et al.
ONCOTARGET (2016)
An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells
Claudia Peitzsch et al.
CANCER RESEARCH (2016)
Caveolin-1: a novel prognostic biomarker of radioresistance in cancer
Javed Mahmood et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2016)
High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting
Peter Hammarsten et al.
PLOS ONE (2016)
The influence of a caveolin-1 mutant on the function of P-glycoprotein
Chih-Yuan Lee et al.
SCIENTIFIC REPORTS (2016)
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients
Erin M. Bertino et al.
CLINICAL LUNG CANCER (2015)
Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway
Wei Zou et al.
ONCOLOGY REPORTS (2015)
Cancer nanomedicine: from targeted delivery to combination therapy
Xiaoyang Xu et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers
Ye Zhang et al.
ONCOTARGET (2015)
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer
Moumita Chatterjee et al.
SCIENTIFIC REPORTS (2015)
P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
Hossam M. Abdallah et al.
JOURNAL OF ADVANCED RESEARCH (2015)
Caveolin-1 Dependent Endocytosis Enhances the Chemosensitivity of HER-2 Positive Breast Cancer Cells to Trastuzumab Emtansine (T-DM1)
Yuan-Chiang Chung et al.
PLOS ONE (2015)
miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1
Ye Zhang et al.
TUMOR BIOLOGY (2015)
The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells
Shannon M. Mumenthaler et al.
CANCER INFORMATICS (2015)
Caveolae and signalling in cancer
Ubaldo E. Martinez-Outschoorn et al.
NATURE REVIEWS CANCER (2015)
Caveolin-1 mediates chemoresistance in breast cancer stem cells via beta-catenin/ABCG2 signaling pathway
Zhiyu Wang et al.
CARCINOGENESIS (2014)
Emerging role of polymerase-1 and transcript release factor (PTRF/Cavin-1) in health and disease
Jin-Yih Low et al.
CELL AND TISSUE RESEARCH (2014)
Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer
L. Liu et al.
ONCOGENE (2014)
PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer
H. Moon et al.
ONCOGENE (2014)
Phosphocaveolin-1 Enforces Tumor Growth and Chemoresistance in Rhabdomyosarcoma
Fiorella Faggi et al.
PLOS ONE (2014)
Loss of Stromal Caveolin-1 Expression: A Novel Tumor Microenvironment Biomarker That Can Predict Poor Clinical Outcomes for Pancreatic Cancer
Tao Shan et al.
PLOS ONE (2014)
Polymerase I and Transcript Release Factor Acts As an Essential Modulator of Glioblastoma Chemoresistance
Xin Wang et al.
PLOS ONE (2014)
Cavin-3 Knockout Mice Show that Cavin-3 Is Not Essential for Caveolae Formation, for Maintenance of Body Composition, or for Glucose Tolerance
Libin Liu et al.
PLOS ONE (2014)
Aberrant Promoter Methylation of Caveolin-1 Is Associated with Favorable Response to Taxane-Platinum Combination Chemotherapy in Advanced NSCLC
Seth A. Brodie et al.
PLOS ONE (2014)
MURC/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by α1-adrenergic receptors
Takehiro Ogata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models
Salahaldin A. Tahir et al.
CANCER BIOLOGY & THERAPY (2013)
Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression
Gustavo Ayala et al.
JOURNAL OF PATHOLOGY (2013)
PTRF/Cavin-1 is Essential for Multidrug Resistance in Cancer Cells
Jae-Sung Yi et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Caveolae as plasma membrane sensors, protectors and organizers
Robert G. Parton et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Caveola-forming proteins caveolin-1 and PTRF in prostate cancer
Zeyad D. Nassar et al.
NATURE REVIEWS UROLOGY (2013)
WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells
G. Yuan et al.
ONCOGENE (2013)
Inherent and Acquired Resistance to Paclitaxel in Hepatocellular Carcinoma: Molecular Events Involved
Avtar Singh Meena et al.
PLOS ONE (2013)
PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis
Zeyad D. Nassar et al.
ONCOTARGET (2013)
Mechanisms and insights into drug resistance in cancer
Hiba Zahreddine et al.
FRONTIERS IN PHARMACOLOGY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Caveolin-1 and Accelerated Host Aging in the Breast Tumor Microenvironment Chemoprevention with Rapamycin, an mTOR Inhibitor and Anti-Aging Drug
Isabelle Mercier et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
Federica Sotgia et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Che-Ming Jack Hu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Genetic Ablation of Cav1 Differentially Affects Melanoma Tumor Growth and Metastasis in Mice: Role of Cav1 in Shh Heterotypic Signaling and Transendothelial Migration
Franco Capozza et al.
CANCER RESEARCH (2012)
Using the reverse Warburg effect to identify high-risk breast cancer patients Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers
Agnieszka K. Witkiewicz et al.
CELL CYCLE (2012)
Expression of PTRF in PC-3 Cells Modulates Cholesterol Dynamics and the Actin Cytoskeleton Impacting Secretion Pathways
Kerry L. Inder et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics
Angelo Gamez-Pozo et al.
PLOS ONE (2012)
Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis
Jacky G. Goetz et al.
CELL (2011)
Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition
Ahmed F. Salem et al.
CELL CYCLE (2011)
Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers
Agnieszka K. Witkiewicz et al.
CELL CYCLE (2011)
Bleomycin treatment of A549 human lung cancer cells results in association of MGr1-Ag and caveolin-1 in lipid rafts
Annett Linge et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Caveolin-1 Orchestrates TCR Synaptic Polarity, Signal Specificity, and Function in CD8 T Cells
Tamar Tomassian et al.
JOURNAL OF IMMUNOLOGY (2011)
High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097
Wei He et al.
MOLECULAR ONCOLOGY (2011)
Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity
Melanie Herzog et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment
Federica Sotgia et al.
BREAST CANCER RESEARCH (2011)
Tumor heterogeneity: Causes and consequences
Andriy Marusyk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2010)
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance
Nicholas B. P. Thomas et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers
Agnieszka K. Witkiewicz et al.
CANCER BIOLOGY & THERAPY (2010)
Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCα phosphorylation
Oscar M. Tirado et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Expression and clinical significance of multidrug resistance proteins in brain tumors
Zhenhua Guo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Changes in Caveolae,Caveolin, and Polymerase 1 and Transcript Release Factor (PTRF) Expression in Prostate Cancer Progression
M. L. Gould et al.
PROSTATE (2010)
RNA interference-directed caveolin-1 knockdown sensitizes SN12CPM6 cells to doxorubicin-induced apoptosis and reduces lung metastasis
Juwon Park et al.
TUMOR BIOLOGY (2010)
Caveolin-1 (P132L), a Common Breast Cancer Mutation, Confers Mammary Cell Invasiveness and Defines a Novel Stem Cell/Metastasis-Associated Gene Signature
Gloria Bonuccelli et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
An Absence of Stromal Caveolin-1 Expression Predicts Early Tumor Recurrence and Poor Clinical Outcome in Human Breast Cancers
Agnieszka K. Witkiewicz et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function
Kerrie-Ann McMahon et al.
EMBO JOURNAL (2009)
Lipid Rafts and Caveolin-1 Coordinate Interleukin-1β (IL-1β)-dependent Activation of NFκB by Controlling Endocytosis of Nox2 and IL-1β Receptor 1 from the Plasma Membrane
Fredrick D. Oakley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
SDPR induces membrane curvature and functions in the formation of caveolae
Carsten G. Hansen et al.
NATURE CELL BIOLOGY (2009)
Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells
Stephanie Hehlgans et al.
RADIOTHERAPY AND ONCOLOGY (2009)
MURC, a muscle-restricted coiled-coil protein, is involved in the regulation of skeletal myogenesis
Masashi Tagawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Role of Caveolin 1, E-Cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells
Elisabet Selga et al.
BMC MEDICAL GENOMICS (2008)
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
Gail D. Lewis Phillips et al.
CANCER RESEARCH (2008)
PTRF-Cavin, a conserved cytoplasmic protein required for Caveola formation and function
Michelle M. Hill et al.
CELL (2008)
Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation
Guang Yang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2008)
Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy
Chao-Chi Ho et al.
LUNG CANCER (2008)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence
Jose A. Karam et al.
PROSTATE (2007)
Modulation of p-glycoprotein function by caveolin-1 phosphorylation
Stephane Barakat et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity
Ayesha N. Shajahan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The multiple faces of caveolae
Robert G. Parton et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
A novel role for caveolin-1 in B lymphocyte function and the development of thymus-independent immune responses
Freddy A. Medina et al.
CELL CYCLE (2006)
Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma
K Nakatani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle
F Capozza et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Caveolin-1 in oncogenic transformation, cancer, and metastasis
TM Williams et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Overexpression of caveolin-1 induces alteration of multidrug resistance in Hs578T breast adenocarcinoma cells
CX Cai et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/Dox
CX Cai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells
J Troost et al.
MOLECULAR PHARMACOLOGY (2004)
Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1
H Zhu et al.
FEBS LETTERS (2004)
Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells
MM Bélanger et al.
CANCER BIOLOGY & THERAPY (2004)
Caveolae: Mining little caves for new cancer targets
LA Carver et al.
NATURE REVIEWS CANCER (2003)
Drug resistance and the microenvironment: nature and nurture
PJ Morin
DRUG RESISTANCE UPDATES (2003)
16HBE14o- human bronchial epithelial cell layers express P-glycoprotein, lung resistance-related protein, and caveolin-1
C Ehrhardt et al.
PHARMACEUTICAL RESEARCH (2003)
Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis
GW Cao et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts
AW Cohen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
The role of caveolin-1 in androgen insensitive prostate cancer
V Mouraviev et al.
JOURNAL OF UROLOGY (2002)
Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae
B Razani et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice
M Drab et al.
SCIENCE (2001)
Upregulation of caveolin in multidrug resistant cancer cells: functional implications
Y Lavie et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities
F Galbiati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries
M Demeule et al.
FEBS LETTERS (2000)
Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences
Y Lavie et al.
GLYCOCONJUGATE JOURNAL (2000)
Share Paper
